Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Interest & Investment Income (2010 - 2026)

Geron (GERN) posted Interest & Investment Income of $3.4 million for Q1 2026, down 15.43% sequentially from $4.0 million in Q4 2025, and down 33.6% YoY from $5.2 million in Q1 2025.

Geron (GERN) Interest & Investment Income (2010 - 2026) Analysis & Trends

Geron has reported Interest & Investment Income for 17 years, with the latest figure at $3.4 million in Q1 2026.

  • Quarterly Interest & Investment Income fell 33.6% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.4 million (down 20.15% YoY) and the FY2025 annual result came in at $18.1 million, down 7.6% from the prior year.
  • Interest & Investment Income eased to $3.4 million in Q1 2026 per GERN's latest filing, from $4.0 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $5.3 million in Q2 2024 and troughed at -$539000.0 in Q1 2022.
  • A 5-year average of $3.6 million and a median of $4.3 million in 2025 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2022 and 2023: Interest & Investment Income tumbled 411.56% in 2022, then surged 1335.76% in 2023.
  • Over 5 years, Interest & Investment Income stood at $1.2 million in 2022, then jumped by 272.15% to $4.6 million in 2023, then climbed by 12.25% to $5.2 million in 2024, then declined by 21.59% to $4.0 million in 2025, then slipped by 15.43% to $3.4 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $3.4 million, $4.0 million, and $4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 Geron 1.02 Mn -299.83 Mn - 2.97 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.97 Mn
Mar 31, 2026 3.42 Mn
Dec 31, 2025 4.05 Mn
Sep 30, 2025 4.26 Mn
Jun 30, 2025 4.66 Mn
Mar 31, 2025 5.15 Mn
Dec 31, 2024 5.16 Mn
Sep 30, 2024 4.88 Mn
Jun 30, 2024 5.33 Mn
Mar 31, 2024 4.24 Mn
Dec 31, 2023 4.60 Mn
Sep 30, 2023 4.97 Mn
Jun 30, 2023 4.74 Mn
Mar 31, 2023 3.85 Mn
Dec 31, 2022 1.24 Mn
Sep 30, 2022 852,000.00
Jun 30, 2022 330,000.00
Mar 31, 2022 -539,000.00
Dec 31, 2021 106,000.00
Sep 30, 2021 112,000.00